biomee™ is developed by MC2 Therapeutics Group. It’s globally distributed by biomee ApS, Denmark – a part of MC2 Group.
We’re dedicated to optimizing the treatment experience and addressing unmet needs for people with autoimmune and chronic inflammatory conditions.
We live by the following rule: Never compromise safety, efficacy, or the way our products feel on the skin.
Troubled skin is often a lifelong condition requiring lifelong care. Sometimes, medical treatment is required. Other times, lifelong relief of symptoms is needed. We specialize in both, using our patented PAD Technology™ as a unique platform for skincare innovation.
The biomee™ skincare line is developed to address specific skin issues. Your feedback is important to us – please don’t hesitate to contact us.